Safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: a prospective cohort study with historical control comparison
Event:
ESC Congress 2023
Topic:
Adult Congenital Heart Disease (ACHD)
Session:
Pharmacotherapy and biomarkers in adult congenital heart disease: do the same rules apply?